News
NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI), a multi-Phase 2 clinical-stage biotechnology company pioneering therapies for central nervous system (CNS) cancers, today announced the closing of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback